Effect of analytic uncertainty of conventional and point-of-care assays of activated partial thromboplastin time on clinical decisions in heparin therapy.

Werner, M; Gallagher, J V; Ballo, M S; Karcher, D S

Werner, M; Gallagher, J V; Ballo, M S; Karcher, D S.

Affiliation

Werner M; Department of Pathology, George Washington University Medical Center, Washington, D.C.

Am J Clin Pathol ; 102(2): 237-41, 1994 Aug.

Article in En | MEDLINE | ID: mdl-8042595

Subject(s)

Blood Coagulation Disorders/prevention & control; Heparin/therapeutic use; Partial Thromboplastin Time; Algorithms; Cardiac Catheterization/adverse effects; Femoral Vein/surgery; Hemorrhage/prevention & control; Heparin/blood; Humans; Myocardial Infarction/drug therapy; Prospective Studies; Reproducibility of Results; Thrombolytic Therapy/adverse effects; Thrombosis/prevention & control

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Partial Thromboplastin Time / Blood Coagulation Disorders / Heparin Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Am J Clin Pathol Year: 1994 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links